ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections (MTG62)Product type:GuidanceProgramme:Medical technologies guidancePublished: 13 December 2021
GID-MT566 Faecal microbiota transplant for recurrent Clostridioides difficile infectionStatus:In developmentProgramme:Medical technologies guidanceExpected publication date: 30 August 2022
Maribavir for treating refractory or resistant cytomegalovirus infection after transplant [ID3900]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 14 September 2022
Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus [ID1203]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
UroShield for preventing catheter-associated urinary tract infections (MTG69)Product type:GuidanceProgramme:Medical technologies guidancePublished: 31 March 2022